10-60317078-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020987.5(ANK3):​c.115-37439C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.579 in 151,754 control chromosomes in the GnomAD database, including 26,062 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.58 ( 26062 hom., cov: 31)

Consequence

ANK3
NM_020987.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0600

Publications

4 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.745 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_020987.5 linkc.115-37439C>A intron_variant Intron 1 of 43 ENST00000280772.7 NP_066267.2
ANK3NM_001204404.2 linkc.64-37439C>A intron_variant Intron 1 of 43 NP_001191333.1
ANK3NM_001320874.2 linkc.115-37439C>A intron_variant Intron 1 of 42 NP_001307803.1
ANK3NM_001204403.2 linkc.97-37439C>A intron_variant Intron 2 of 43 NP_001191332.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000280772.7 linkc.115-37439C>A intron_variant Intron 1 of 43 1 NM_020987.5 ENSP00000280772.1

Frequencies

GnomAD3 genomes
AF:
0.579
AC:
87857
AN:
151636
Hom.:
26046
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.460
Gnomad AMI
AF:
0.603
Gnomad AMR
AF:
0.641
Gnomad ASJ
AF:
0.686
Gnomad EAS
AF:
0.711
Gnomad SAS
AF:
0.767
Gnomad FIN
AF:
0.566
Gnomad MID
AF:
0.677
Gnomad NFE
AF:
0.609
Gnomad OTH
AF:
0.617
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.579
AC:
87919
AN:
151754
Hom.:
26062
Cov.:
31
AF XY:
0.583
AC XY:
43242
AN XY:
74162
show subpopulations
African (AFR)
AF:
0.461
AC:
19029
AN:
41312
American (AMR)
AF:
0.641
AC:
9796
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.686
AC:
2377
AN:
3466
East Asian (EAS)
AF:
0.710
AC:
3636
AN:
5122
South Asian (SAS)
AF:
0.766
AC:
3679
AN:
4804
European-Finnish (FIN)
AF:
0.566
AC:
5979
AN:
10558
Middle Eastern (MID)
AF:
0.680
AC:
200
AN:
294
European-Non Finnish (NFE)
AF:
0.609
AC:
41374
AN:
67914
Other (OTH)
AF:
0.619
AC:
1303
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1811
3623
5434
7246
9057
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
748
1496
2244
2992
3740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.586
Hom.:
4479
Bravo
AF:
0.575
Asia WGS
AF:
0.708
AC:
2462
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
7.9
DANN
Benign
0.82
PhyloP100
-0.060
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10761481; hg19: chr10-62076836; API